Effect of Telmisartan on Histological Activity and Fibrosis of Non-alcoholic Steatohepatitis: A 1-Year Randomized Control Trial

BACKGROUND/AIM: Telmisartan can attenuate two hit pathogenesis of non-alcoholic steatohepatitis (NASH). This study aimed to observe the effect of Telmisartan on non-alcoholic fatty liver disease (NAFLD) activity score (NAS) and fibrosis score in NASH patients. PATIENTS AND METHODS: A total of 50 NAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Shahinul, Kabir, Jahangir, Mustafa, Golam, Gupta, UtpalDas, Hasan, SKMNazmul, Alam, AKMKhorshed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763532/
https://www.ncbi.nlm.nih.gov/pubmed/26831610
http://dx.doi.org/10.4103/1319-3767.173762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763532/
https://www.ncbi.nlm.nih.gov/pubmed/26831610
http://dx.doi.org/10.4103/1319-3767.173762

Ejemplares similares